• Hong Wu and Dian Wang.
• Department of Physical Medicine and Rehabilitation, Medical College of Wisconsin, Milwaukee, WI 53045, USA.
• Clin J Pain. 2007 Nov 1;23(9):826-8.

AbstractNumerous potential complications are associated with the use of programmable intrathecal (IT) drug delivery systems. Radiation is often assumed to cause dysfunctions of the programmable IT device. However, radiation-induced failure of this device and limits of dose exposure have not clinically documented. Here we reported an alarm and failure of an implanted programmable IT pump in a turn-off status exposed directly to radiation used for treatment of a retroperitoneal sarcoma. The radiation-induced alarm was likely secondary to the electronic circuit damage and/or battery depletion. Estimated cumulative doses to the pump were in the range of 28.5 to 36 Gy when the alarm occurred after 20 daily treatments. The IT pump itself exposed to this high-dose radiation did not pose any risk to the patient or the environment. This is the first case description about the pump malfunction secondary to clinical radiotherapy, which is very useful to physicians who manage the pain and radiotherapy for cancer patients.

19 keywords...

hide…